Combination contraceptive
First Claim
Patent Images
1. A product that contains in combination individual dosage units of a competitive progesterone antagonist and individual dosage units of a gestagen useful for its sequential, oral administration, in which the amount of the competitive progesterone antagonist in each of its individual dosage units is non-ovulation-inhibiting and non-abortion-inducing.
4 Assignments
0 Petitions
Accused Products
Abstract
This invention relates to a combination product that consists of individual dosage units of a competitive progesterone antagonist and, in addition, sequentially provided individual dosage units of a compound with gestagenic action, as well as its use for the production of contraceptives based on the inhibition of implantation (receptivity inhibition).
62 Citations
23 Claims
- 1. A product that contains in combination individual dosage units of a competitive progesterone antagonist and individual dosage units of a gestagen useful for its sequential, oral administration, in which the amount of the competitive progesterone antagonist in each of its individual dosage units is non-ovulation-inhibiting and non-abortion-inducing.
- 13. A method of contraception, comprising administering to a patient an effective amount of a competitive progesterone antagonist and an effective amount of a gestagen, wherein the amount of said competitive progesterone antagonist does not inhibit ovulation or induce abortion.
Specification